MygoGenesis™ Is Unleashing the Power of Cellular Medicine. The Mygotic™ proprietary process turns somatic cells to totipotent cells and then to any cell or tissue. It is revolutionizing Cell Therapy, Gene Therapy, and Regenerative medicine. It is a Pipeline within a Process.The Initial Focus of MygoGenesis™ is on Four Product Pathways to Commercialization with More in the Pipeline:*AmeboGenesis™- Laboratory Amebocyte Production for Producers of LAL, the Gold Standard for Pharma and Medical Device Safety Testing for Bacterial Endotoxins.*HematoGenesis™- Limitless Production of Human Blood Focusing on Type O Negative Blood and Platelets*MyCellSafe™-Be Your Best Donor for Autologous Totipotent Cells, Always Available for Every Patient and Every Treatment and Regenerative Medicine*The Production of a Broad Range Cells for Research

SolomonCFO assists closely-held and emerging growth Bio-Tech, Software and Healthcare companies in the areas of corporate finance, accounting, fundraising and M&A.